CH-II Langerhans cell histiocytosis: treatment protocol of the second international study
Completed
- Conditions
- angerhans cell histiocytosisHaematological DisordersCertain diseases involving lymphoreticular tissue and reticulohistiocytic system
- Registration Number
- ISRCTN57679341
- Lead Sponsor
- K Co-ordinating Committee for Cancer Research (UKCCCR)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 193
Inclusion Criteria
1. Definitive diagnosis of Langerhans cell histiocytosis
2. Aged under 18 years with involvement of haematopetic system, liver, lungs or spleen or aged under 2 years
3. No prior treatment for Langerhans cell histiocytosis
Exclusion Criteria
Does not comply with above criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration